Biased Ligands. Better Drugs.

Oliceridine pivotal Phase 3 soft-tissue results (APOLLO-2)

APOLLO‐2: A Randomized, Placebo and Active‐Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein–Biased Ligand at the μ‐Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty

Neil K. Singla MD, Franck Skobieranda MD, David G. Soergel MD, Monica Salamea BA, David A. Burt PhD, Mark A. Demitrack MD, Eugene R. Viscusi MD

View Publication

Copyright © Trevena, Inc.